Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Organon & Co. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 728 | 13 | 733 | +18 |
| Shares | 199.0M | 294.1K | 198.8M | +138.3K (+0.1%) |
| Value | $4.13B | $6.39M | $3.45B | −$667.9M (−16.2%) |
13 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (72)
Institutions that held Organon & Co. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (54)
Institutions that held Organon & Co. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (13)
Institutions that held Organon & Co. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Sabadell Asset Management, S.A S.G.I.I.C | 135,053 | $2.78M |
| Nia Impact Advisors, LLC | 107,810 | $2.55M |
| Pictet Asset Management SA | 45,734 | $951.7K |
| Kistler-Tiffany Companies, LLC | 3,608 | $75.1K |
| First Capital Advisors Group, LLC. | 806 | $16.8K |
| Endurance Wealth Management, Inc. | 424 | $9.00K |
| BDO Wealth Advisors, LLC | 219 | $4.56K |
| Coastal Capital Group, Inc. | 197 | $4.10K |
| BerganKDV Wealth Management, LLC | 98 | $2.04K |
| First Command Bank | 76 | $1.58K |
| First Command Financial Services, Inc. | 76 | $1.58K |
| First National Bank of South Miami | 10 | $208 |
| Northwest Bank & Trust Co | 6 | $124 |